Physician profile
John Wuellner
NPI 1558378927
$1,326.78
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $388 · 2021: $71.47 · 2022: $349 · 2024: $36.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $329.47 | 2019-2022 | |
| Amgen INC. | $101.52 | 2019-2022 | |
| Glaxosmithkline, LLC. | $92.29 | 2019 | |
| Abbvie INC. | $80.73 | 2021-2022 | |
| Astellas Pharma US INC | $77.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $67.25 | 2019-2022 | |
| Pfizer INC. | $52.26 | 2019-2022 | |
| Amarin Pharma, INC. | $50.64 | 2019-2020 | |
| Lilly USA, LLC | $48.98 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $46.04 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $45.01 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.17 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $37.04 | 2020-2022 | |
| Abbott Laboratories | $36.99 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.71 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $24.88 | 2022 | |
| Merck Sharp & Dohme LLC | $24.74 | 2022 | |
| Lifescan, INC. | $22.64 | 2020 | |
| Calliditas Therapeutics US INC. | $21.01 | 2024 | |
| Eisai INC. | $16.16 | 2020 | |
| Stryker Corporation | $15.87 | 2024 | Aequalis Perform Reversed |
| Otsuka America Pharmaceutical, INC. | $14.34 | 2021 | |
| Nestle Healthcare Nutrition INC. | $14.00 | 2022 | |
| Apria Healthcare LLC | $13.18 | 2021 | |
| Allergan, INC. | $13.09 | 2020 | |
| Sunovion Pharmaceuticals INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wuellner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.